Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PTSC v TPL

Apparently TPL requested a third extension of time and opposition has been registered. Awaiting the court's decision. TPL's reply brief is due Oct 6th.

It is my understanding that the purpose of the reply brief is to enable TPL to argue any new material which is not already covered in the orgininal briefs. If no new material, then the reply brief is unnecessary. Corrections welcomed.

Opty

Share
New Message
Please login to post a reply